Global Bevacizumab Biosimilar Market Research Report Forecast 2017 to 2022

November 2017 | 123 pages | ID: GC3BF9FE1DFEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global Bevacizumab Biosimilar Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Bevacizumab Biosimilar industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bevacizumab Biosimilar market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Bevacizumab Biosimilar Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Global Bevacizumab Biosimilar Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global Bevacizumab Biosimilar Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab Biosimilar
1.2 Bevacizumab Biosimilar Market Segmentation by Type
  1.2.1 Global Production Market Share of Bevacizumab Biosimilar by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Bevacizumab Biosimilar Market Segmentation by Application
  1.3.1 Bevacizumab Biosimilar Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Bevacizumab Biosimilar Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Bevacizumab Biosimilar (2012-2022)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON BEVACIZUMAB BIOSIMILAR INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

3.1 Global Bevacizumab Biosimilar Production and Share by Manufacturers (2015 and 2016)
3.2 Global Bevacizumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Bevacizumab Biosimilar Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution, Production Area and Product Type
3.5 Bevacizumab Biosimilar Market Competitive Situation and Trends
  3.5.1 Bevacizumab Biosimilar Market Concentration Rate
  3.5.2 Bevacizumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL BEVACIZUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Bevacizumab Biosimilar Production by Region (2012-2017)
4.2 Global Bevacizumab Biosimilar Production Market Share by Region (2012-2017)
4.3 Global Bevacizumab Biosimilar Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL BEVACIZUMAB BIOSIMILAR SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Bevacizumab Biosimilar Consumption by Regions (2012-2017)
5.2 North America Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL BEVACIZUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Bevacizumab Biosimilar Production and Market Share by Type (2012-2017)
6.2 Global Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
6.3 Global Bevacizumab Biosimilar Price by Type (2012-2017)
6.4 Global Bevacizumab Biosimilar Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION

7.1 Global Bevacizumab Biosimilar Consumption and Market Share by Application (2012-2017)
7.2 Global Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL BEVACIZUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

8.1 Pfizer
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Allergan
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Alnylam Pharmaceuticals
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Amgen
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Angstrom Pharmaceuticals
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Acceleron Pharma
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Biocon
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Bionomics
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 CASI Pharmaceuticals
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

9.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Bevacizumab Biosimilar Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

13.1 Global Bevacizumab Biosimilar Production, Revenue Forecast (2017-2022)
13.2 Global Bevacizumab Biosimilar Production, Consumption Forecast by Regions (2017-2022)
13.3 Global Bevacizumab Biosimilar Production Forecast by Type (2017-2022)
13.4 Global Bevacizumab Biosimilar Consumption Forecast by Application (2017-2022)
13.5 Bevacizumab Biosimilar Price Forecast (2017-2022)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Figure Global Production Market Share of Bevacizumab Biosimilar by Type in 2016
Table Bevacizumab Biosimilar Consumption Market Share by Application in 2016
Figure North America Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Bevacizumab Biosimilar Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Bevacizumab Biosimilar Capacity of Key Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Bevacizumab Biosimilar Capacity of Key Manufacturers in 2015
Figure Global Bevacizumab Biosimilar Capacity of Key Manufacturers in 2016
Table Global Bevacizumab Biosimilar Production of Key Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Production Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Biosimilar Production Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Production Share by Manufacturers
Table Global Bevacizumab Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table Global Market Bevacizumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Bevacizumab Biosimilar Average Price of Key Manufacturers in 2016
Table Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Bevacizumab Biosimilar Product Type
Figure Bevacizumab Biosimilar Market Share of Top 3 Manufacturers
Figure Bevacizumab Biosimilar Market Share of Top 5 Manufacturers
Table Global Bevacizumab Biosimilar Capacity by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Capacity Market Share by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Bevacizumab Biosimilar Capacity Market Share by Regions
Table Global Bevacizumab Biosimilar Production by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Production and Market Share by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Production Market Share by Regions (2012-2017)
Figure 2015 Global Bevacizumab Biosimilar Production Market Share by Regions
Table Global Bevacizumab Biosimilar Revenue by Regions (2012-2017)
Table Global Bevacizumab Biosimilar Revenue Market Share by Regions (2012-2017)
Table 2015 Global Bevacizumab Biosimilar Revenue Market Share by Regions
Table Global Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table China Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table India Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Bevacizumab Biosimilar Consumption Market by Regions (2012-2017)
Table Global Bevacizumab Biosimilar Consumption Market Share by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Bevacizumab Biosimilar Consumption Market Share by Regions
Table North America Bevacizumab Biosimilar Production, Consumption, Import & Export (2012-2017)
Table Europe Bevacizumab Biosimilar Production, Consumption, Import & Export (2012-2017)
Table China Bevacizumab Biosimilar Production, Consumption, Import & Export (2012-2017)
Table Japan Bevacizumab Biosimilar Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Bevacizumab Biosimilar Production, Consumption, Import & Export (2012-2017)
Table India Bevacizumab Biosimilar Production, Consumption, Import & Export (2012-2017)
Table Global Bevacizumab Biosimilar Production by Type (2012-2017)
Table Global Bevacizumab Biosimilar Production Share by Type (2012-2017)
Figure Production Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure 2015 Production Market Share of Bevacizumab Biosimilar by Type
Table Global Bevacizumab Biosimilar Revenue by Type (2012-2017)
Table Global Bevacizumab Biosimilar Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure 2015 Revenue Market Share of Bevacizumab Biosimilar by Type
Table Global Bevacizumab Biosimilar Price by Type (2012-2017)
Figure Global Bevacizumab Biosimilar Production Growth by Type (2012-2017)
Table Global Bevacizumab Biosimilar Consumption by Application (2012-2017)
Table Global Bevacizumab Biosimilar Consumption Market Share by Application (2012-2017)
Figure Global Bevacizumab Biosimilar Consumption Market Share by Application in 2015
Table Global Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
Figure Global Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Bevacizumab Biosimilar Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Bevacizumab Biosimilar Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Bevacizumab Biosimilar Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Acceleron Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acceleron Pharma Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Bevacizumab Biosimilar Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Bevacizumab Biosimilar Market Share (2012-2017)
Table Bionomics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bionomics Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Bevacizumab Biosimilar Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CASI Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure Global Bevacizumab Biosimilar Production and Growth Rate Forecast (2017-2022)
Figure Global Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Table Global Bevacizumab Biosimilar Production Forecast by Regions (2017-2022)
Table Global Bevacizumab Biosimilar Consumption Forecast by Regions (2017-2022)
Table Global Bevacizumab Biosimilar Production Forecast by Type (2017-2022)
Table Global Bevacizumab Biosimilar Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals